References
- Jager U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the first international consensus meeting. Blood Rev. 2020;41:100648. doi:10.1016/j.blre.2019.100648.
- Fattizzo B, Barcellini W. Autoimmune hemolytic anemia: causes and consequences. Expert Rev Clin Immunol. 2022;18(7):731–745. doi:10.1080/1744666X.2022.2089115.
- Barcellini W, Fattizzo B. The changing landscape of autoimmune hemolytic anemia. Front Immunol. 2020;11:946. doi:10.3389/fimmu.2020.00946.
- Michalak SS, Olewicz-Gawlik A, Rupa-Matysek J, Wolny-Rokicka E, Nowakowska E, Gil L. Autoimmune hemolytic anemia: current knowledge and perspectives. Immun Age. 2020;17(1):38. doi:10.1186/s12979-020-00208-7.
- Barcellini W, Fattizzo B, Zaninoni A. Current and emerging treatment options for autoimmune hemolytic anemia. Expert Rev Clin Immunol. 2018;14(10):857–872. doi:10.1080/1744666X.2018.1521722.
- Voulgaridou A, Kalfa TA. Autoimmune hemolytic anemia in the pediatric setting. J Clin Med. 2021;10(2):216. doi:10.3390/jcm10020216.
- Mayer B, Yurek S, Kiesewetter H, Salama A. Mixed-type autoimmune hemolytic anemia: differential diagnosis and a critical review of reported cases. Transfusion. 2008;48(10):2229–2234. doi:10.1111/j.1537-2995.2008.01805.x.
- Berentsen S, Sundic T. Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy. Biomed Res Int. 2015;2015:363278. doi:10.1155/2015/363278.
- Cascio MJ, DeLoughery TG. Anemia: evaluation and diagnostic tests. Med Clin North Am. 2017;101(2):263–284. doi:10.1016/j.mcna.2016.09.003.
- Barcellini W. New insights in the pathogenesis of autoimmune hemolytic anemia. Transfus Med Hemother. 2015;42(5):287–293. doi:10.1159/000439002.
- Barcellini W, Fattizzo B. Clinical applications of hemolytic markers in the differential diagnosis and management of hemolytic anemia. Dis Markers. 2015;2015:635670. doi:10.1155/2015/635670.
- Barcellini W, Giannotta J, Fattizzo B. Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures. Expert Rev Hematol. 2020;13(6):585–597. doi:10.1080/17474086.2020.1754791.
- Berentsen S, Barcellini W, Longo DL. Autoimmune Hemolytic Anemias. N Engl J Med. 2021;385(15):1407–1419. doi:10.1056/NEJMra2033982.
- Van De Loosdrecht V, Hendriks H, Blom B, Smit S, De Wolf DE, Vellenga V. Excessive apoptosis of bone marrow erythroblasts in a patient with autoimmune haemolytic anaemia with reticulocytopenia. Br J Haematol. 2000;108(2):313–315. doi:10.1046/j.1365-2141.2000.01867.x.
- Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica. 2014;99(10):1547–1554. doi:10.3324/haematol.2014.114561.
- Packman CH. Hemolytic anemia due to warm autoantibodies. Blood Rev. 2008;22(1):17–31. doi:10.1016/j.blre.2007.08.001.
- Bu X, Zhang T, Wang C, Ren T, Wen Z. IL-33 reflects dynamics of disease activity in patients with autoimmune hemolytic anemia by regulating autoantibody production. J Transl Med. 2015;13(1):381. doi:10.1186/s12967-015-0745-0.
- Garratty G. The James Blundell award lecture 2007: do we really understand immune red cell destruction? Transfus Med. 2008;18(6):321–334. doi:10.1111/j.1365-3148.2008.00891.x.
- McGrath JP. Assessment of hemolytic and hemorrhagic anemias in preclinical safety assessment studies. Toxicol Pathol. 1993;21(2):158–163. doi:10.1177/019262339302100207.
- Ru YX, Zhu XF, Gao JT, et al. Ultrastructural characteristics of nucleated cells in bone marrow of patients with acquired aplastic anemia. Ultrastruct Pathol. 2008;32(3):81–88. doi:10.1080/01913120802063099.